CorrlensCorrlens
Correlate

Correlation Analysis

BERKSHIRE HATHAWAY Class B vs Regeneron Pharmaceuticals Inc

BRK.B vs REGN

+0.211

Light positive

When one moves up, the other tends to follow.

BRK.B logo

BERKSHIRE HATHAWAY Class B

BRK.B

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from its operations to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis. Berkshire is expected to generate close to $375 billion in revenue in 2025.

Market cap 1T

REGN logo

Regeneron Pharmaceuticals Inc

REGN

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Market cap 80.7B · 15,410 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: BRK.BGray: REGN36 of 1,254 points (sampled)

Who Moves First

REGN leads BRK.B by 6 days

REGN tends to move before BRK.B.

After testing 13 timing shifts, the strongest relationship was +0.219 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.505

15 periods · Return correlation when both series rose

Both Falling

-0.933

7 periods · Return correlation when both series fell

Diverging

-0.635

13 periods · Return correlation when series moved apart

R-Squared

4.4%

Share of variance in one series explained by the other.

Trend Agreement

63.4%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.157, 0.263]

Scatter

XY Regression

247250300350400450500522.14226008001,0001,198BERKSHIRE HATHAWAY Class BRegeneron Pharmaceuticals IncData pointsFit (r = 0.211)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

BRK.B logo

BERKSHIRE HATHAWAY Class B

BRK.B

Market cap 1T

Stock · 1,254 raw → 1,254 prepared

Series B

REGN logo

Regeneron Pharmaceuticals Inc

REGN

Market cap 80.7B · 15,410 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

20

Estimated crossover points between normalized spreads.

Slope

0.3892

Linear regression slope.

Intercept

586.1044

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 7 hours ago · ID: stock-brk-b-vs-stock-regn-daily